10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Integrative neuroimaging analysis characterized nigrostriatal neuron degeneration.

          • Correlation of NRC SN with SBR clearly differed from that of PSP with CBS.

          • In MSA-P, interhemispheric laterality of SBR coincided with putamen atrophy.

          • No significant correlation occurred between NRC SN and SBR in MSA-P.

          • Parkinsonian disorders are divisible into two groups based on NRC SN-SBR correlation.

          Abstract

          Introduction

          The present study characterized the degeneration of nigrostriatal dopaminergic neurons in the early stages of parkinsonian disorders using integrative neuroimaging analysis with neuromelanin-sensitive MRI and 123I-FP-CIT dopamine transporter (DAT) SPECT.

          Methods

          Thirty-one, 30, and 29 patients with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS) with abnormal specific binding ratio (SBR) in either hemisphere (mean ± 2SD), and parkinsonism-predominant multiple system atrophy (MSA-P), respectively, were enrolled. Neuromelanin-related contrast (NRC) in the substantia nigra (NRC SN) and locus coeruleus (NRC LC) and the SBR of DAT SPECT were measured. All the patients underwent both examinations simultaneously within five years after symptom onset. After adjusting for interhemispheric asymmetry on neuromelanin-related MRI contrast using the Z-score, linear regression analysis of the NRC SN and SBR was performed for the most- and least-affected hemispheres, as defined by the interhemispheric differences per variable (SBR, NRC SN, standardized [SBR + NRC SN]) in each patient.

          Results

          Although the variables did not differ significantly between PSP and CBS, a significant correlation was found for CBS in the most-affected hemisphere for all the definitions, including the clinically defined, most-affected hemisphere. No significant correlation was found between the NRC SN and SBR for any of the definitions in either PSP or MSA-P.

          Conclusion

          Together with the findings of our previous study of dementia with Lewy bodies (DLB) and Parkinson’s disease (PD), the present findings indicated that neural degeneration in the disorders examined may be categorized by the significance of the NRC SN-SBR correlation in PD and CBS and its non-significance in DLB, PSP, and MSA-P.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

          PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Criteria for the diagnosis of corticobasal degeneration.

            Current criteria for the clinical diagnosis of pathologically confirmed corticobasal degeneration (CBD) no longer reflect the expanding understanding of this disease and its clinicopathologic correlations. An international consortium of behavioral neurology, neuropsychology, and movement disorders specialists developed new criteria based on consensus and a systematic literature review. Clinical diagnoses (early or late) were identified for 267 nonoverlapping pathologically confirmed CBD cases from published reports and brain banks. Combined with consensus, 4 CBD phenotypes emerged: corticobasal syndrome (CBS), frontal behavioral-spatial syndrome (FBS), nonfluent/agrammatic variant of primary progressive aphasia (naPPA), and progressive supranuclear palsy syndrome (PSPS). Clinical features of CBD cases were extracted from descriptions of 209 brain bank and published patients, providing a comprehensive description of CBD and correcting common misconceptions. Clinical CBD phenotypes and features were combined to create 2 sets of criteria: more specific clinical research criteria for probable CBD and broader criteria for possible CBD that are more inclusive but have a higher chance to detect other tau-based pathologies. Probable CBD criteria require insidious onset and gradual progression for at least 1 year, age at onset ≥ 50 years, no similar family history or known tau mutations, and a clinical phenotype of probable CBS or either FBS or naPPA with at least 1 CBS feature. The possible CBD category uses similar criteria but has no restrictions on age or family history, allows tau mutations, permits less rigorous phenotype fulfillment, and includes a PSPS phenotype. Future validation and refinement of the proposed criteria are needed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

              We carried out an investigation to identify neuromelanin-containing noradrenergic and dopaminergic neurons in the locus ceruleus and substantia nigra pars compacta of healthy volunteers and patients with Parkinson's disease using a newly developed magnetic resonance imaging technique that can demonstrate neuromelanin-related contrast. The high-resolution neuromelanin images obtained by a 3-T scanner revealed high signal areas in the brain stem and these corresponded well with the location of the locus ceruleus and substantia nigra pars compacta in gross specimens. In Parkinson's disease patients, the signal intensity in the locus ceruleus and substantia nigra pars compacta was greatly reduced, suggesting depletion of neuromelanin-containing neurons. We conclude that neuromelanin magnetic resonance imaging can be used for direct visualization of the locus ceruleus and substantia nigra pars compacta, and may help in detecting pathological changes in Parkinson's disease and related disorders.
                Bookmark

                Author and article information

                Contributors
                Journal
                Clin Park Relat Disord
                Clin Park Relat Disord
                Clinical Parkinsonism & Related Disorders
                Elsevier
                2590-1125
                15 February 2024
                2024
                15 February 2024
                : 10
                : 100242
                Affiliations
                [a ]Department of Neurology, Tokyo Metropolitan Neurological Hospital (TMNH), Tokyo, Japan
                [b ]Department of Neuroradiology, TMNH, Tokyo, Japan
                Author notes
                [* ]Corresponding author. keizo_sugaya@ 123456tmhp.jp
                Article
                S2590-1125(24)00011-2 100242
                10.1016/j.prdoa.2024.100242
                10883825
                38405025
                575722b5-a824-4471-89a2-23afa5def7ad
                © 2024 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 12 October 2023
                : 9 February 2024
                : 13 February 2024
                Categories
                Original Article

                nigrostriatal dopaminergic degeneration,neuromelanin-sensitive mri,dopamine transporter spect,corticobasal degeneration,progressive supranuclear palsy,multiple system atrophy

                Comments

                Comment on this article